Nifty slumps amidst selling in IT stocks and as uncertainty over the India-US trade seal also weighed on investors sentiment.

Nifty (-191, 25164)
Sensex (-667, 82523)
Bank Nifty (-292, 56664)

Nifty (CMP: 25164)

SUPPORT: 25000/24297
RESISTANCE: 25443/25670
TRADING RANGE (25100-24300)

SECTOR GAINER:

Nifty FMCG (+0.88%)
NIFTY PHARMA (+0.65%)

SECTOR LOSER:

NIFTY IT (-1.78%)
NIFTY MEDIA (-1.43%)
NIFTY AUTO (-1.36%)

Top Index Gainers:
HUL (+4.69%)
SBI LIFE (0.97%)
NESTLE (0.78%)
AXIS BANK (+0.58%)
SUN PHARMA (0.52%)

Top Index Losers:
TCS (-2.85%)
M&M (-2.44%)
APOLLO HOSPITAL (-2.43%)
WIPRO (-2.32%)
BHARTI AIRTEL (-2.22%)

KEY THEMES FOR THE DAY:

TCS stock price plummets 3.09% after its June quarter earnings fail to enthuse investors.

Nifty bulls also receiving fresh drubbing amidst:

1) Trump tariff uncertainties’
2) Hawkish remarks from the Fed’s Musalem.

Gold prices ($3333 per ounce) was seen consolidating with positive bias on the backdrop of a tempered Federal Reserve dovish outlook offset concerns over renewed trade tensions.

3) Our call of the day suggests that tariff volatility is back on the front pages and the negative takeaway is that there is no end in sight for tariff uncertainties.

4) India VIX drops towards 11.87 levels.

3) Bank Nifty (-0.53%) drifts lower, indicating desired unwind of long positions amidst overbought technical conditions.

Bank Nifty’s fresh all-time-high is at 57628.40 mark.

4) Nifty’s biggest support is placed at 25000 mark. Confirmation of strength only above 25670 mark.

12:30 PM GLOBAL UPDATE:

Dow Futures: (-148, 44503)
Nasdaq 100 Futures (-43, 22788)

Nikkei (-153, 39485)
Hang Seng (+306, 24334)

Dollar Index (+0.14%, 97.79)
WTI OIL (+0.72%, 67.03)
Gold (+013, 3337)

Securities in Ban for Trade Date: Friday, July 11th 2025
RBL BANK
HIND COPPER

STOCKS IN SPOTLIGHT:

1) Glenmark Pharma (+13.5%) soars on AbbVie licensing deal for cancer therapy ISB 2001.

Glenmark Pharmaceuticals’ subsidiary Ichnos Glenmark Innovation (IGI) unveiled a global commercialization strategy for its lead investigational oncology asset, ISB 2001.

Disclaimer/ Disclosure: The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points does not construe investment advice as stock market investments are subject to market risks so please refer to your financial consultant advice before Investing or trading. All information is a point of view, and is for educational, Learning and informational use only. The author or the group admin accepts no liability for any interpretation of articles or comments on this platform being used for actual investments. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investors must make their own investment decisions based on their specific investment objectives, goals and financial position only after consulting with registered market intermediaries.

🇮🇳 🇮🇳 🙏🏻

GIFT Nifty 🇮🇳: (-122, 25282)

TCS Q1FY26 was above street expectation but we suspect is unlikely to move the needle in favor of IT stocks.

TCS Q1 profit was up 6%. The company has blamed ‘geo-political uncertainties which has caused demand contraction’

Our call of the day suggests IT stocks can witness massive rebound only if the Federal Reserve turns ultra-dovish.

Traders will now eye Q1 results of IT stocks like:
14th July: HCL Tech
16th July: LTTS, Tech Mahindra
17th July: LTIM
23rd July: Infosys

Nifty bulls are likely to receive fresh drubbing also amidst:

1) Trump tariff uncertainties’
2) Hawkish remarks from the Fed’s Musalem.

Technically, confirmation of strength only above Nifty 25670 mark.

Now, the 3-positive catalysts:

1) WTI crude oil futures fell 2% to below $67 per barrel as traders digested news that OPEC+ may pause planned output hikes starting in October.

2) In yesterday’s trade, FIIs turned out to be net buyers to the tune of Rupees 221 crores while DII were net buyers to the tune of Rupees 591 crores.

3) India VIX, the fear index has slumped towards 11.67 levels.

The Gyan Mantra: Stay nimble as there could be some “whipsaw” in the near term.

Amongst stock specific action:

1) Emcure Pharmaceuticals (+1.98%) advanced after the U.S. Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) at its manufacturing facility (Oncology) located at G.I.D.C., Sanand, Ahmedabad, Gujarat.

2) HDFC AMC (+1.28%) and NAM India (+1.8%) on reports that the net inflow into equity mutual funds surged 24% to Rs 23,587 crore in June, reversing the declining trend of the last five months

Now, here is the preferred trade on Nifty and Bank Nifty:

Nifty (25355): Sell at CMP. Stop at 25771. Targets 25221/25000. Aggressive targets at 24700-24900 zone.

Bank Nifty (56956): Sell at CMP. Stop at 58151. Targets 56500/56100. Aggressive targets at 55000-55300 zone.

Our chart of the day is bullish on HDFC AMC, MARUTI and M&M on any early excessive intraday weakness with an interweek perspective.

The 1 Stock to Buy Now: Buy HDFC AMC (CMP 5208): Buy at CMP. Stop at 4951. Targets 5279/5369. Aggressive targets at 5501. (Interweek Strategy). Likely to enjoy strong session as long as 4983 support is held. Massive breakout play on the daily charts is quite likely as the recent sequence of higher high/low is intact on time-frames. Confirmation of strength only above 5279.

Disclaimer/ Disclosure: The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points does not construe investment advice as stock market investments are subject to market risks so please refer to your financial consultant advice before Investing or trading. All information is a point of view, and is for educational, Learning and informational use only. The author or the group admin accepts no liability for any interpretation of articles or comments on this platform being used for actual investments. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investors must make their own investment decisions based on their specific investment objectives, goals and financial position only after consulting with registered market intermediaries.

🇮🇳 🇮🇳 🙏🏻

Nifty is seen treading water as bulls seen unimpressed by strong overnight gains at Wall Street in overnight trade.

Nifty (-93, 25383)
Sensex (-301, 83235)
Bank Nifty (-68, 57148)

Nifty (CMP: 25383)

SUPPORT: 25221/25001
RESISTANCE: 25670/26277
TRADING RANGE (25300-24550)

SECTOR GAINER:

Nifty RETAIL (+0.38%)

SECTOR LOSER:

NIFTY PHARMA (-0.93%)
NIFTY IT (-0.83%)
NIFTY INFRA (-0.49%)

Top Index Gainers:
MARUTI (+0.71%)
INDUSIND BANK (+0.68%)
ULTRATECH CEMENT (+0.62%)
JIO FINANCIAL (+0.55%)
AXIS BANK (+0.51%)

Top Index Losers:
BHARTI AIRTEL (-1.69%)
TECH MAHINDRA (-1.32%)
CIPLA (-1.19%)
COAL INDIA (-1.18%)
SUN PHARMA (-1.13%)

KEY THEMES FOR THE DAY:

1) A little bit feeling of anxiousness and nervousness seen ahead of news of US-India tariff deal.

2) Stock markets across the globe are trading with caution after US President Donald Trump insisted on the bulk of US trading partners will actually kick in on August 1.

3) Our call of the day suggests that tariff volatility is likely to keep investors on the sidelines and the negative takeaway is that there is no end in sight for tariff uncertainties.

4) India VIX trades sluggish near the 12.10 levels.

5) Bank Nifty (-0.09%) inches a tad lower, indicating desired consolidation to be the preferred theme for the day.

Bank Nifty’s fresh all-time-high is at 57628.40 mark.

6) Nifty’s biggest support is placed at 25221 mark. Confirmation of strength only above 25670 mark.

7) ‘Fed Minutes from the June 17-18 FOMC Meeting Minutes point to lower inflation ahead’

8) TCS officially sets afire the ceremonial starters pistol for Q1 earning season on July 10th after market hours. TCS press conference is likely at 5:30 pm

TCS officially sets afire the ceremonial starters pistol for Q1 earning season on July 10th after market hours.

TCS press conference is likely at 5:30 pm

11:30 AM GLOBAL UPDATE:

Dow Futures: (-87, 44373)
Nasdaq 100 Futures (-53, 22812)

Nikkei (-285, 39545)
Hang Seng (+81, 23972)

Dollar Index (+0.11%, 97.37)
WTI OIL (-0.03%, 68.36)
Gold (+9, 3322)

Securities in Ban for Trade Date: Thursday, July 10th 2025
RBL BANK
HINDUSTAN COPPER

STOCKS IN SPOTLIGHT:

1) Emcure Pharmaceuticals (+1.29%) advanced after the U.S. Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) at its manufacturing facility (Oncology) located at G.I.D.C., Sanand, Ahmedabad, Gujarat.

2) Orient Technologies shed 0.59% after the company announced that it has received a purchase order worth Rs 29.86 crore from Protean eGov Technologies for the procurement, setup, and support of AWS infrastructure.

Disclaimer/ Disclosure: The investments & trading ideas recommended in the market analysis, research reports, etc. may not be suitable for all investors. This article or data points does not construe investment advice as stock market investments are subject to market risks so please refer to your financial consultant advice before Investing or trading. All information is a point of view, and is for educational, Learning and informational use only. The author or the group admin accepts no liability for any interpretation of articles or comments on this platform being used for actual investments. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Investors must make their own investment decisions based on their specific investment objectives, goals and financial position only after consulting with registered market intermediaries.

🇮🇳 🇮🇳 🙏🏻